CCR5 and HIV infectious disease: CCR5-fostered therapeutic approaches to block HIV infection to date, including small molecule inhibitors, chemically modified ligands, and anti-CCR5 antibodies, have shown their antiviral properties in cell-based tests and in in vivo trials [56,89,90].